$NRXP @NRxPharma NRx Pharmaceuticals Sets Sights on Debut Commercial Revenue in 2024, Unveils Innovative Advances in Bi-Annual Progress Report: (Nasdaq: NRXP) https://www.kxan.com/business/press-releases/ein-presswire/709692023/nrx-pharmaceuticals-eyes-first-commercial-revenue-in-2024-announces-breakthroughs-in-bi-annual-milestones-nasdaq-nrxp/